While You Were Socially Distancing – Washington Has Been Busy: Summary of the Top Rules Impacting Providers and Payors for 2021

While you were occupied with COVID response, the federal agencies responsible for regulating health care providers and payors have been busy. Erin Eiselein and Anna-Liisa Mullis will provide an update on new or revised rules impacting providers and payors for 2021.

Highlights include:

• The new interoperability rules (data access/CURES Act).
• Changes to Part 2 regulations and to the Part 2 authorizing law in the CARES Act.
• Litigation over the changes to the Section 1557 definition under the ACA (including removal of health care protections for transgender individuals).
• Executive orders on drug pricing.
• Status of court challenge to hospital price transparency rule.
• The D.C. Circuit ruling on the site of service changes.
• The delay on final Stark regulations until August 2021.
  
  

A seasoned litigator, Erin Eiselein counsels clients on a wide variety of disputes and regulatory issues facing the health care industry. Representing health care practitioners, community health organizations, medical device companies and hospital systems, Erin has a unique understanding of both the law and the constantly evolving regulatory, political and business issues impacting the health care industry. 

Anna-Liisa Mullis has a background representing health care organizations and professionals in a variety of matters before trial and appellate courts, as well as in private arbitration. Her work has included both defending and prosecuting a multitude of complex matters, including disputes involving hospital-provider contracting, hospital-vendor contracting, hospital-physician joint ventures, physician-owned entities and provider-payor disputes as well as antitrust disputes in the healthcare sector. Along with her litigation practice, Anna-Liisa also works closely with clients on analyzing and advising on a wide variety of fraud and abuse, patient privacy, data and innovation matters.